首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Magnitude and determinants of short-term tachyphylaxis to methacholine in subjects with symptomatic or asymptomatic airway hyperresponsiveness and in normal controls.
【24h】

Magnitude and determinants of short-term tachyphylaxis to methacholine in subjects with symptomatic or asymptomatic airway hyperresponsiveness and in normal controls.

机译:有症状或无症状气道高反应性受试者和正常对照组中对苯甲胆碱的短期速激肽反应的幅度和决定因素。

获取原文
获取原文并翻译 | 示例
       

摘要

Tachyphylaxis to methacholine has been reported in nonasthmatic subjects. In a recent study on the prevalence of airway hyperresponsiveness (AHR) and atopy, we performed duplicate methacholine inhalation tests at a 60-min interval, in subjects with symptomatic asthma (n = 33), asymptomatic AHR (AAHR) (n = 72) and in a group of normal subjects (n = 130); 135/235 subjects were atopic. All subjects had a respiratory questionnaire, allergy skin prick tests, blood eosinophil counts and determination of total serum IgE level. In asthmatic subjects, PC20 just failed to be significantly higher on a second methacholine challenge (p = 0.09); when they were stratified according to severity of AHR and use of inhaled corticosteroids, we observed a significant increase in PC20 on the second test in asthmatic subjects with mild AHR not using corticosteroids (p < 0.01). In normal controls, PC20 methacholine was slightly increased on rechallenge (p < 0.01) as it was in those with AAHR (p < 0.01). There was no relationship between the magnitude of the change in PC20 and age, sex, baseline airway responsiveness, percent fall in FEV1 on the first challenge, atopic score, blood eosinophil counts and serum IgE levels. In conclusion, tachyphylaxis to methacholine is observed in normal or mild asthmatic subjects not using inhaled corticosteroids and in subjects with AAHR; however, in most subjects this change is of a small magnitude.
机译:非哮喘患者中已报道对乙酰甲胆碱的速激肽治疗。在最近的一项关于气道高反应性(AHR)和特应性疾病患病率的研究中,我们以60分钟的间隔对有症状哮喘(n = 33),无症状AHR(AAHR)(n = 72)的受试者进行了重复的甲胆碱吸入试验在一组正常受试者中(n = 130); 135/235名受试者患有特应性。所有受试者均进行了呼吸问卷调查,过敏性皮肤点刺试验,血液嗜酸性粒细胞计数以及总血清IgE水平的测定。在哮喘患者中,第二次乙酰甲胆碱攻击后,PC20未能显着升高(p = 0.09)。当根据AHR的严重程度和吸入皮质类固醇的使用对它们进行分层时,我们在第二次试验中观察到轻度AHR不使用皮质类固醇的哮喘受试者的PC20显着增加(p <0.01)。在正常对照组中,再挑战时PC20乙酰甲胆碱略有增加(p <0.01),与AAHR患者相比(p <0.01)。 PC20变化的幅度与年龄,性别,基线气道反应性,首次挑战时FEV1下降百分比,特应性评分,血液嗜酸性粒细胞计数和血清IgE水平之间没有关系。总之,在未使用吸入皮质类固醇的正常或轻度哮喘受试者以及患有AHR的受试者中,观察到对乙酰甲胆碱的速激肽抑制作用。但是,在大多数受试者中,这种变化幅度很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号